Literature DB >> 20099504

Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.

D T Arioz1, H Camuzcuoglu, H Toy, S Kurt, H Celik, O Erel.   

Abstract

PURPOSE OF INVESTIGATION: Serum paraoxonase (PON 1) is one of the most important enzymatic antioxidants that hydrolyzes lipid peroxidation, an indicator of carcinogenic activity. The aim of this study was to compare the serum levels of paraoxonase and arylesterase activity in patients with endometrial cancer to those of healthy controls.
METHODS: Serum paraoxonase and arylesterase activities, total free sulphydryl (-SH) groups and lipid hydroperoxide (LOOH) levels were measured in patients with endometrial cancer (n = 20) and controls (n = 23).
RESULTS: Serum paraoxonase, arylesterase activities and total -SH group levels were significantly lower in patients compared to controls (p < 0.05, p < 0.05 and p < 0.001; respectively), while LOOH levels were significantly higher (p < 0.001). Among patients, serum paraoxonase and arylesterase activities were inversely correlated with LOOH levels (r = -0.680, p < 0.05; r = -0.708, p < 0.001; respectively), while these were positively correlated with the total -SH group (r = 0.526, p < 0.05; r = 0.508, p < 0.05; respectively).
CONCLUSION: Reduced serum PON 1 activity might contribute to an impaired antioxidant defense system which plays a critical role in carcinogenesis in patients with endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20099504

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  5 in total

1.  Paraoxonase and arylesterase activity in bladder cancer.

Authors:  Mehmet Mazhar Utanğaç; Ercan Yeni; Murat Savaş; Adem Altunkol; Halil Çiftçi; Kemal Gümüş; Mehmet Demir
Journal:  Turk J Urol       Date:  2017-05-03

2.  Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease.

Authors:  Paul Dowling; Catriona Hayes; Kay Reen Ting; Abdul Hameed; Justine Meiller; Constantine Mitsiades; Kenneth C Anderson; Martin Clynes; Colin Clarke; Paul Richardson; Peter O'Gorman
Journal:  BMC Genomics       Date:  2014-10-17       Impact factor: 3.969

3.  Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells.

Authors:  Mark Borris D Aldonza; Yeon Sung Son; Hye-Jin Sung; Jung Mo Ahn; Young-Jin Choi; Yong-In Kim; Sukki Cho; Je-Yoel Cho
Journal:  Oncotarget       Date:  2017-06-27

4.  The importance of antioxidant status in gastric intestinal metaplasia.

Authors:  Nilay Danis; Aysegul Ertinmaz Ozkan; Fatih Karatas; Cagri Cakici; Turkan Yigitbasi; Nurhayat Ozkan Sevencan; Burcak Kayhan
Journal:  J Med Biochem       Date:  2021-09-03       Impact factor: 3.402

5.  Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Authors:  Jung-Mo Ahn; Hye-Jin Sung; Yeon-Hee Yoon; Byung-Gyu Kim; Won Suk Yang; Cheolju Lee; Hae-Min Park; Bum-Jin Kim; Byung-Gee Kim; Soo-Youn Lee; Hyun-Joo An; Je-Yoel Cho
Journal:  Mol Cell Proteomics       Date:  2013-10-01       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.